Dr. Lee Gazourian, MD

Dr. Gazourian practices at Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health.

Dr. Gazourian's NPI, 1598774291, was assigned on August 5, 2006. Dr. Gazourian graduated from Boston University School Of Medicine in 2003. Dr. Gazourian holds Massachusetts license 226772.

Dr. Gazourian's primary practice is Lahey Clinic, at 41 & 45 Mall Road, Burlington, MA 01803 in Middlesex County. The practice phone is (781) 744-5100.

Dr. Gazourian's primary practice is Lahey Clinic in Burlington, Massachusetts, part of Beth Israel Lahey Health. Dr. Gazourian is also affiliated with Beverly Hospital. The medical group on file is Lahey Clinic. Dmand AI also links Dr. Gazourian to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gazourian practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Gazourian's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Gazourian is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Gazourian is licensed in Massachusetts.

CMS data shows 168 Medicare services from Dr. Gazourian across 5 procedure codes in 2024, for 93 Medicare patients. Medicare paid $23,028 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 93 Medicare patients who saw Dr. Gazourian in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gazourian's median patient age at 77, with 64% women.

In 2024, Dr. Gazourian wrote 58 Medicare Part D claims for 24 patients. 38% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $1,544 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Gazourian for performance year 2024, reported through an alternative payment model (APM). Dr. Gazourian accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 16 papers to Dr. Gazourian, published from 2012 to 2023. 2013 was the busiest year, with 3. The most frequent topics are Early Detection of Cancer, Lung Neoplasms and Tomography, X-Ray Computed. Dr. Gazourian has published most often in Respir Med. Dr. Gazourian's most frequent co-authors are George R. Washko, MD, Laura E. Fredenburgh, MD and Vincent Trien-Vinh Ho, MD.

Dmand AI links Dr. Gazourian to 1 clinical trial. Conditions studied include Lung Diseases, Interstitial and Lung Diseases.

CMS Open Payments shows 15 general payments to Dr. Gazourian from 8 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 87% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $8,619.

Dr. Gazourian graduated from Boston University School Of Medicine in 2003.

Dr. Gazourian is in network with 10 carriers, including Excellus BlueCross BlueShield, United Healthcare and Aetna. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.